• Ranolazine Teva 375 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	375 mg

  ATC: C01E C01EB C01EB18

• Ranolazine Teva 500 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	500 mg

  ATC: C01E C01EB C01EB18

• Ranolazine Teva 750 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	750 mg

  ATC: C01E C01EB C01EB18

• Rasagiline Ratio 1 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  RASAGILINE MESYLATE	1,56 mg

  ATC: N04B N04BD N04BD02

• Rasagiline Teva-Ratio 1 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  RASAGILINE MESYLATE	1,56 mg

  ATC: N04B N04BD N04BD02

• Risperidone Flas Teva-Ratiopharm 0.5 mg orodispersible tablets EFG

  Form: tablets, buccodispersable

  Active substance	Dosage
  RISPERIDONE	0,5 mg

  ATC: N05A N05AX N05AX08

• Risperidone Flas Teva-Ratiopharm 1 mg orodispersible tablets EFG

  Form: tablets, buccodispersable

  Active substance	Dosage
  RISPERIDONE	1,00 mg

  ATC: N05A N05AX N05AX08

• Risperidone Flas Teva-Ratiopharm 2 mg orodispersible tablets EFG

  Form: tablets, buccodispersable

  Active substance	Dosage
  RISPERIDONE	2,00 mg

  ATC: N05A N05AX N05AX08

• Risperidone Ratio 6 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  RISPERIDONE	6,0 mg

  ATC: N05A N05AX N05AX08

• Risperidone Teva 1 mg/ml oral solution EFG

  Form: solution, oral

  Active substance	Dosage
  RISPERIDONE	1.000 mg

  ATC: N05A N05AX N05AX08

• Risperidone Teva 25 mg powder and solvent for prolonged-release injection suspension EFG

  Form: powder and solvent for preparation of prolonged-release injectable suspension

  Active substance	Dosage
  RISPERIDONE	25 mg

  ATC: N05A N05AX N05AX08

• Risperidone Teva 37.5 mg powder and solvent for prolonged-release injectable suspension EFG

  Form: powder and solvent for preparation of prolonged-release injectable suspension

  Active substance	Dosage
  RISPERIDONE	37,5 mg

  ATC: N05A N05AX N05AX08

• Risperidone Teva 50 mg powder and solvent for prolonged-release injection suspension EFG

  Form: powder and solvent for preparation of prolonged-release injectable suspension

  Active substance	Dosage
  RISPERIDONE	50 mg

  ATC: N05A N05AX N05AX08

• Risperidone Teva-Ratio 1 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  RISPERIDONE	1 mg

  ATC: N05A N05AX N05AX08

• Risperidone Teva-Ratio 3 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  RISPERIDONE	3 mg

  ATC: N05A N05AX N05AX08

• Risperidone Teva-Ratio 6 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  RISPERIDONE	6 mg

  ATC: N05A N05AX N05AX08

• Rivastigmine Teva 13.3 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	27 mg

  ATC: N06D N06DA N06DA03

• Rivastigmine Teva 4.6 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	9 mg

  ATC: N06D N06DA N06DA03

• Rivastigmine Teva 9.5 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	18 mg

  ATC: N06D N06DA N06DA03

• Rizatriptan Teva-Ratiopharm 10 mg orodispersible tablets EFG

  Form: tablets, buccodispersable

  Active substance	Dosage
  RIZATRIPTAN BENZOATE	14,53 mg

  ATC: N02C N02CC N02CC04

• Ropinirole Teva 4 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  ROPINIROLE HYDROCHLORIDE	4,56 mg

  ATC: N04B N04BC N04BC04

• Ropinirole Teva 8 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  ROPINIROLE HYDROCHLORIDE	9,12 mg

  ATC: N04B N04BC N04BC04

• Rosuvastatin Teva-Ratiopharm 10 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  ROSUVASTATIN CALCIUM	10,42 mg

  ATC: C10A C10AA C10AA07

• Rosuvastatin Teva-Ratiopharm 20 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  ROSUVASTATIN CALCIUM	20,83 mg

  ATC: C10A C10AA C10AA07

• Rosuvastatin Teva-Ratiopharm 5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  ROSUVASTATIN CALCIUM	5,21 mg

  ATC: C10A C10AA C10AA07

• Rupatadine Teva 10 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  RUPATADINE FUMARATE	12,77 mg

  ATC: R06A R06AX R06AX28

• Sapropterin Teva 100 mg soluble tablets EFG

  Form: tablets, soluble

  Active substance	Dosage
  Sapropterin Dihydrochloride	100 mg

  ATC: A16A A16AX A16AX07

• Sertraline Davur 100 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SERTRALINE HYDROCHLORide	111,9 mg

  ATC: N06A N06AB N06AB06

• Sertraline Davur 50 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SERTRALINE HYDROCHLORide	55,95 mg

  ATC: N06A N06AB N06AB06

• Sertraline Teva-Ratio 100 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SERTRALINE HYDROCHLORide	111,9 mg

  ATC: N06A N06AB N06AB06

• Sertraline Teva-Ratio 50 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SERTRALINE HYDROCHLORide	55,95 mg

  ATC: N06A N06AB N06AB06

• Sevelamer Ratiopharm 2,4 g powder for oral suspension

  Form: powder for preparation of oral suspension

  Active substance	Dosage
  Sevelamer Carbonate	2400 mg

  ATC: V03A V03AE V03AE02

• Sevelamer Teva 800 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  Sevelamer Carbonate	836 mg

  ATC: V03A V03AE V03AE02

• Sevelamer Teva-Ratiopharm 2.4 g powder for oral suspension

  Form: powder for preparation of oral suspension

  Active substance	Dosage
  Sevelamer Carbonate	Igual a 2400.0 mg mg

  ATC: V03A V03AE V03AE02

• Sibudel 250 mg solution for injection in pre-filled syringe EFG

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  FULVESTRANT	250 mg

  ATC: L02B L02BA L02BA03

• Silodosin ratiopharm 8 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  SILODOSIN	8 mg

  ATC: G04C G04CA G04CA04

• Simvastatin Davur 10 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SIMVASTATIN	10 mg

  ATC: C10A C10AA C10AA01

• Simvastatin Davur 20 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SIMVASTATIN	20 mg

  ATC: C10A C10AA C10AA01

• Simvastatin Davur 40 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SIMVASTATIN	40 mg

  ATC: C10A C10AA C10AA01

• Simvastatin Teva-Ratio 10 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SIMVASTATIN	10 mg

  ATC: C10A C10AA C10AA01

• Simvastatin Teva-Ratio 20 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SIMVASTATIN	20 mg

  ATC: C10A C10AA C10AA01

• Simvastatin Teva-Ratio 40 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SIMVASTATIN	40 mg

  ATC: C10A C10AA C10AA01

• SindiAr 2 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  LOPERAMIDE HYDROCHLORIDE	2 mg

  ATC: A07D A07DA A07DA03

• Sitagliptin Teva 100 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SITAGLIPTIN MALEATE	132,920 mg

  ATC: A10B A10BH A10BH01

• Sitagliptin Teva 25 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SITAGLIPTIN MALEATE	33,230 mg

  ATC: A10B A10BH A10BH01

• Sitagliptin Teva 50 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SITAGLIPTIN MALEATE	66,460 mg

  ATC: A10B A10BH A10BH01

• Sitagliptin/metformin Teva 50 mg/1,000 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  METFORMIN HYDROCHLORIDE	1.000 mg
  SITAGLIPTIN HYDROCHLORIDE	54,47 mg

  ATC: A10B A10BD A10BD07

• Solifenacin Teva 10 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SOLIFENACIN SUCCINATE	10 mg

  ATC: G04B G04BD G04BD08

• Solifenacin Teva 5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SOLIFENACIN SUCCINATE	5 mg

  ATC: G04B G04BD G04BD08

• Sorafenib Teva 200 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SORAFENIB TOSYLATE	274 mg

  ATC: L01E L01EX L01EX02